A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals
- 1 August 2008
- Vol. 377 (2) , 255-264
- https://doi.org/10.1016/j.virol.2008.04.029
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting ImmunityJournal of Virology, 2007
- Successful Topical Respiratory Tract Immunization of Primates against Ebola VirusJournal of Virology, 2007
- Nonsegmented Negative-Strand Viruses as Vaccine VectorsJournal of Virology, 2006
- Efficacy of Severe Acute Respiratory Syndrome Vaccine Based on a Nonhuman Primate Adenovirus in the Presence of Immunity Against Human AdenovirusHuman Gene Therapy, 2006
- A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus ChallengeJournal of Virology, 2006
- Recombinant Newcastle Disease Virus Expressing a Foreign Viral Antigen Is Attenuated and Highly Immunogenic in PrimatesJournal of Virology, 2005
- Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway EpitheliumJournal of Virology, 2005
- Other viral bioweapons: Ebola and Marburg hemorrhagic feverDermatologic Clinics, 2004
- Neutralizing Antibodies and CD8 + T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine VectorsJournal of Virology, 2004
- Accelerated Migration of Respiratory Dendritic Cells to the Regional Lymph Nodes Is Limited to the Early Phase of Pulmonary InfectionImmunity, 2003